AG
VRTX icon

AlTi Global’s Vertex Pharmaceuticals VRTX Stock Holding History

AlTi Global’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301K Sell
673
-89
-12% -$41.5K 0.01% 365
2025
Q4 		$345K Buy
+762
New +$328K 0.01% 359
2024
Q3 		– Sell
-431
Closed -$202K – 411
2024
Q2 		$202K Sell
431
-477
-53% -$207K 0.01% 369
2024
Q1 		$380K Buy
908
+294
+48% +$124K 0.01% 287
2023
Q4 		$250K Buy
+614
New +$227K 0.01% 313

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AlTi Global's VRTX Position: Q1 2026 in Review

AlTi Global reduced its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, selling an estimated $41.5K and leaving 673 shares worth $301K. The position accounts for 0.01% of the portfolio, ranked #365.

AlTi Global first reported a position in VRTX in Q4 2023 and has held it in 5 quarters since. The position peaked at $380K in Q1 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • AlTi Global held 673 shares of Vertex Pharmaceuticals worth $301K as of Q1 2026.
  • AlTi Global sold 89 Vertex Pharmaceuticals shares in Q1 2026, an estimated $41.5K.
  • Vertex Pharmaceuticals made up 0.01% of AlTi Global's portfolio in Q1 2026, its #365 holding.
  • AlTi Global first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • AlTi Global's Vertex Pharmaceuticals position peaked at $380K in Q1 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on AlTi Global's 13F filing for Q1 2026, filed 7 May 2026.